Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,392 public trials 2,847 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Assess the Oral Bioavailability of New ABT-263 Formulations

NCT00743028

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations: Site Reference ID/Investigator# 10281 Encinitas, California, United States

Site Reference ID/Investigator# 10282 Santa Monica, California, United States

Site Reference ID/Investigator# 16341 Bethesda, Maryland, United States

Site Reference ID/Investigator# 9441 Lebanon, New Hampshire, United States

View Trial Details

Completed

Anagrelide vs. Hydroxyurea - Efficacy and Tolerability Study in Patients With Essential Thrombocythaemia

NCT01065038

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations: Center AKH Vienna, State of Vienna, Austria

Center Hanusch Vienna, State of Vienna, Austria

Center Innsbruck Innsbruck, Tyrol, Austria

Center Brno Brno, Czechia

View all 24 locations

View Trial Details

Completed

The Effect of Heparin in Treatment IVF-ET Failure

NCT01214772

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Pregnancy, +1 more
Locations: Yazd Research and Clinical Centre for Infertility Yazd, Yazd Province, Iran

View Trial Details

Completed

Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

NCT00002510

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
Locations: Temple University Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer

NCT00002809

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +30 more
Locations: Fox Chase-Temple Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

NCT00002521

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +20 more
Locations: Fox Chase - Temple Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis

NCT00002810

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Fox Chase-Temple Cancer Center CCOP Research Base Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML

NCT00382954

Conditions: Acute Myelogenous Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations: University of Kentucky Lexington, Kentucky, United States

University of Rochester Rochester, New York, United States

View Trial Details

Completed

VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia

NCT00505700

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel/ Deaconess Medical Center Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia

NCT00006097

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations: Boston Medical Center Boston, Massachusetts, United States

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions